BioPharmaStock
HomeAsk About StockNewsIdeasHistoryFDA DesignationsElite Program

ACHV

No price yet

Announcements

Nothing here yet

Daily updates

Nothing here yet

FDA designations

Nothing here yet

News

  • Achieve Life Sciences presents 52-week safety data for continuous cytisinicline treatmentMay 20, 2026
  • Achieve Life Sciences reported operational progress including completion of technology transfer to Adare Pharma SolutionsApr 15, 2026
  • Achieve Life Sciences published data linking cytisinicline receptor selectivity to improved tolerabilityMar 26, 2026
  • Achieve Life Sciences presented SRNT data showing successful smoking cessation in heavily pretreated smokers and insights from the ORCA-OL study experienceMar 4, 2026
  • Achieve Life Sciences receives FDA Commissioner's national priority voucher for cytisinicline for treatment of nicotine dependence for e-cigarette or vaping cessationOct 17, 2025

    Bio Pharma Stock

    Where Science Meets Investing.

    BioPharmaStock is a specialized biopharmaceutical investment intelligence company focused exclusively on publicly traded biotechnology and pharmaceutical companies. Our research team continuously analyzes clinical trials, FDA regulatory events, scientific publications, corporate developments, and market catalysts to deliver timely research and exclusive insights for investors seeking opportunities in one of the world's most knowledge-intensive sectors.

    ALNJAM ALAALI SOFTWARE DESIGN CO. L.L.C, UAE, Abu Dhabi

    BioPharmaStock LogoBioPharmaStock Logo

    Quick Links

    • Home
    • Ask About Stock
    • News
    • Ideas
    • History
    • FDA Designations
    • Elite Program

    Contact Us

    Email: info@biopharmastock.com

    Phone: +971 50 936 3328

    Join Our Community→

    Follow Us

    Get the App

    Instant notifications on your phone

    Download on theApp StoreGet it onGoogle Play

    © 2026 Bio Pharma Stock. All rights reserved. Policy